Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Liver Cirrhosis, Experimental D008106 36 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukopenia D007970 9 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Leiomyosarcoma D007890 4 associated lipids
Polycystic Kidney Diseases D007690 12 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Kidney Diseases D007674 29 associated lipids
Keratitis D007634 7 associated lipids
Jejunal Diseases D007579 3 associated lipids
Intermittent Claudication D007383 6 associated lipids
Influenza, Human D007251 11 associated lipids
Inflammation D007249 119 associated lipids
Infertility D007246 3 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Hypothyroidism D007037 32 associated lipids
Hypotension D007022 41 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Wang H [Alteration of thromboxane A2/prostacyclin and their effect on spinal cord blood flow in experimental spinal cord injury in rats]. 1993 Zhonghua Wai Ke Za Zhi pmid:8033727
Mao E et al. [Pancreatic ischemia: a continuous injury factor in acute necrotic pancreatitis]. 1997 Zhonghua Wai Ke Za Zhi pmid:10374521
Xing X et al. [Preserving remnant liver function after major hepatic vein occlusion]. 1998 Zhonghua Wai Ke Za Zhi pmid:11825430
Xing X and Xia S [The injury of liver sinusoidal endothelial cells in a rat's isolated liver perfusion (ILP) model for regional chemotherapy]. 1996 Zhonghua Wai Ke Za Zhi pmid:9275689
Xiao J et al. [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury]. 1995 Zhonghua Wai Ke Za Zhi pmid:8762548
Miao XY [Plasma level and effects of thromboxane A2 and 6-keto-PGF1 alpha in patients with acute obstructive suppurative cholangitis]. 1990 Zhonghua Wai Ke Za Zhi pmid:2379443
Wang ZG et al. [Experimental study and clinical application of endothelium seeded vena caval prostheses]. 1994 Zhonghua Wai Ke Za Zhi pmid:7842898
Yu HZ [Determinations of CSF and plasma concentrations of thromboxane B2 and 6-keto-PGF1 alpha in stroke patients]. 1988 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3402273
Gao XG [Plasma concentrations of thromboxane B2 and 6-keto-PGF1 alpha in patients with cerebral hemorrhage]. 1988 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3402274
Jiang K [The study of occurrence mechanism in acute and chronic cerebral vasospasm]. 1992 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:1304997
Cao QL [Dynamic analysis of plasma TXB2 determined by radioimmunoassay in 30 cases of cerebral infarction]. 1986 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3743234
Xie P [Clinical significance of TXB2 level in CSF of patients with acute cerebrovascular diseases]. 1986 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3743244
Zhao J [Treatment of acute cerebral infarction with PGI2--evaluating the clinical effect and observation of dynamic changes in plasma TXB2 and 6-keto PGF1 alpha levels]. 1991 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:1889319
Teng Y [The effect of hyperbaric oxygenation on prostaglandin I2 and thromboxane A2 during reperfusion for experimental cerebral ischemia in rabbits]. 1992 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:1591957
Sun B et al. [The experimental observation on the procedure of atherosclerotic restenosis following PTCA]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697911
Liu H et al. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697924
Pan YZ et al. [The clinical significance of platelet activation during exercise-induced myocardial ischemia]. 1994 Zhonghua Nei Ke Za Zhi pmid:7520851
Zheng L et al. [Changes of thromboxane A2 (TXA2) and prostacyclin (PGI2) in COPD patients with pulmonary hypertension]. 1991 Zhonghua Nei Ke Za Zhi pmid:1864178
Liu HY et al. [Changes in parameters of hemorheology and circulation 6-keto-PGF1 alpha and TXB2 in dilated cardiomyopathy]. 1991 Zhonghua Nei Ke Za Zhi pmid:1874088
Yu NC et al. [Changes in plasma 6-keto-PGF1 alpha, TXB2 lipid peroxides in acute cerebral infarction patients and the effects of Salvia miltiorrhiza on these three indices]. 1988 Zhonghua Nei Ke Za Zhi pmid:3229180